Unicycive Therapeutics (UNCY) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Unicycive Therapeutics (UNCY) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Unicycive Therapeutics

· UNCY

Dashboard

Financials

Ratios

Valuation

Statistics

127.416 M

+0.53%

General

Market Cap: $126.74M
Enterprise Value: $83.18M
Shares Outstanding: 26,700,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -48.90%
ROE: -88.81%
ROIC: -61.44%
Current Ratio: 3.81
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 2.38
EV/EBITDA: -2.41

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $32.93M
Operating Income: -$33.14M
Net Profit: -$35.22M

Balance Sheet

Cash and Equivalents: $44.19M
Working Capital: $52.62M
Total Assets: $72.03M
Net Debt: -$43.51M
Total Liabilities: $18.76M
Total Equity: $53.27M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$27.84M
Cash Flow from Investing: -$17.25M
Cash Flow from Financing: $66.95M
Free Cash Flow: -$27.85M
Capital Expenditures: $9K